VivaDiag SARS-CoV-2 Ag Rapid Test

These assessments needs to be used as a part of a totally built-in COVID-19 methodology, serving to seek out out these contaminated to cut once more the unfold of the virus. VivaDiag™ SARS-CoV-2 Ag Fast Confirm has ONLY been designed to behave as a supplementary look at for suspected conditions of detrimental coronavirus nucleic acid detection or along with nucleic acid detection all through the analysis of suspected conditions. Outcomes from nucleocapsid protein antigen testing shouldn’t be used because the one precise foundation to diagnose or exclude SARS-CoV-2 (COVID-19) an an an infection or to tell an an an infection standing.

VivaDiag SARS-CoV-2 Ag Fast Confirm is dependent upon immunoassay know-how for the speedy, qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in human oropharyngeal or nasopharyngeal swab specimens. The look at generates a end consequence inside 15 minutes figuring out folks contaminated with COVID-19 rapidly serving to to comprise the unfold of the virus.

The bundle accommodates all gadgets required together with swab, extraction tube, extraction resolution and lateral circulation look at system. No specialised gear or personnel is required to make the most of this look at. The assessments is also carried out in any setting at any time by educated personnel, i.e for knowledgeable use solely

This lateral circulation Covid-19 Fast Antigen Confirm Instruments is for easy for educated personnel to deal with delivering acceptable outcomes quickly utilizing the oropharyngeal or nasopharyngeal swab specimen.

With the specimen collected insert the swab into the extraction tube filled with extraction resolution. Having eradicated a testing system from the sealed pouch apply three drops of the reply and wait 15 minutes before discovering out the look at, a optimistic or detrimental consequence’s clearly indicated.

This Covid-19 Fast Antigen Confirm Instruments has an regular accuracy of 98.79%, a specificity of 99.12% and a sensitivity of 90.90% offering full assurance of quick, acceptable, dependable outcomes.

Precept and meant use

Immupass VivaDiag SARS-CoV-2 Ag Fast Confirm is meant for medical laboratories and healthcare knowledgeable use just for point-of-care testing. Not for at-home testing.

Immupass VivaDiag™ SARS-CoV-2 Ag Fast Confirm is dependent upon immunoassay know-how. Every look at system has one line of anti-SARS coronavirus monoclonal antibody on the detection line (T line) and one line of anti-mouse IgG polyclonal antibody on the same old administration line (C line).

When extracted specimen is added to the specimen accurately, it must react with the labeled antibody to type a flowery, the combination then migrates by the use of the membrane by capillary motion and interacts with the coated anti-SARS coronavirus monoclonal antibody on the detection line. If the specimen accommodates SARS-CoV-2 antigen, the detection line will seem purplish-red indicating the SARS-CoV-2 antigen is optimistic. In one other case, the look at end consequence shall be detrimental. The look at system furthermore accommodates a top quality administration line C which must look purplish-red for all skilled assessments. If the same old administration line C wouldn’t seem, the look at end consequence shall be invalid even when the detection line seems.

Composition

Every look at bundle accommodates: 25 look at gadgets, 25 extraction tubes (prefilled with extraction resolution 300 μL / tube), filtered nozzles, 1 tube stand, 25 sterile swabs and 1 bundle insert.

Supplies required however could not supplied: timer.

Specification

SARS-CoV-2 Antigen Rapid Test Kit
abx294181-20g	Abbexa	20 µg	EUR 100

SARS-CoV-2 Antigen Rapid Test Kit
abx294181-50g	Abbexa	50 µg	EUR 450

SARS-CoV-2 Antigen Rapid Test Kit
CoV2Ag-1	UnScience	1T	EUR 9.6
Description: This kit adopts the sandwich method and the technical principle of colloidal gold immunochromatography to qualitative determine the SARS-CoV-2 antigen. During the test, the sample is dropped into the sample well, and chromatography is performed under the capillary effect. The SARS-CoV-2 antigen in the sample combined with the colloidal goldlabeled SARS-CoV-2 monoclonal antibody I, and then spread to the test area. It is captured by another coated antibody (SARS-CoV-2 monoclonal antibody II), to form a complex and gather in the test area (T line). The quality control area is coated with the goat antimouse antibody, and the colloidal gold-labeled antibody is captured to form a complex and aggregate in the quality control area (C line). If the C line does not show color, it indicates that the result is invalid, and this sample needs to be tested again.

SARS-CoV-2 Antigen Rapid Test Kit
CoV2Ag-25	UnScience	25T/kit	EUR 42
Description: This product is used for in vitro qualitative detection of SARS-CoV-2 antigen in human oropharyngeal swabs, nasal swabs and nasopharyngeal swabs. It is helpful as an aid in the screening of early mild, asymptomatic, or acute patients for identification of SARS-CoV-2 infection.

SARS-CoV-2 Antigen Rapid Test Kit
GF101A2	Shenzhen Lvshiyuan Biotechnology	25 Test/kit	Ask for price

SARS-CoV-2 IgG/IgM Rapid Test Kit
abx294171-100g	Abbexa	100 µg	EUR 1525

SARS-CoV-2 IgG/IgM Rapid Test Kit
abx294171-20g	Abbexa	20 µg	EUR 187.5

SARS-CoV-2 IgG/IgM Rapid Test Kit
abx294171-50g	Abbexa	50 µg	EUR 337.5

SARS-CoV-2 Rapid Antigen Test Nasal
9901-NCOV-03G	Roche Diagnostics	25 Tests/Kit	EUR 112.8
Description: The SARS-CoV-2 Rapid Antigen Test is a lateral fl ow rapid chromatographic immunoassay for the qualitative detection of nucleocapsid antigen to SARS-CoV-2 present in human nasal samples. This test is intended for use as an aid in detection of SARS-CoV-2 infection in individuals suspected of COVID-19 with clinical symptoms onset within 5 days. Results are for the identification of SARS-CoV-2 nucleocapsid antigen. Antigen is generally detectable in human nasal swab samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co- infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The SARS-CoV-2 Rapid Antigen Test is intended for use in laboratory or POC settings by healthcare professionals, or self-collection under the supervision of a healthcare worke

SARS-CoV-2-Spike Antibody Rapid Test Kit
abx090710-100l	Abbexa	100 µl	EUR 650

SARS-CoV-2-Spike Antibody Rapid Test Kit
abx090710-1ml	Abbexa	1 ml	EUR 10500

SARS-CoV-2-Spike Antibody Rapid Test Kit
abx090710-200l	Abbexa	200 µl	EUR 2100

SARS-CoV-2 Neutralization Antibody Rapid Test Kit
abx092242-100l	Abbexa	100 µl	EUR 1925

SARS-CoV-2 Neutralization Antibody Rapid Test Kit
abx092242-1ml	Abbexa	1 ml	EUR 22500

SARS-CoV-2 Neutralization Antibody Rapid Test Kit
abx092242-200l	Abbexa	200 µl	EUR 6600